|
Real-world evidence (RWE) to show improved time to progression among resected pancreatic cancer (RPC) patients receiving adjuvant chemotherapy (adjch). |
|
|
No Relationships to Disclose |
|
|
Employment - Cardinal Health |
Leadership - Cardinal Health |
Stock and Other Ownership Interests - Cardinal Health |
Travel, Accommodations, Expenses - Cardinal Health |
|
|
Employment - Genentech; Hoechst; Newlink Genetics |
Stock and Other Ownership Interests - Durect Corporation; NewLink Genetics |
|
|
Employment - Genentech; Newlink Genetics |
Stock and Other Ownership Interests - Newlink Genetics |
|
|
Employment - Cardinal Health |
Stock and Other Ownership Interests - Cardinal Health |
|
|
Consulting or Advisory Role - Cardinal Health (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |